Achieve Life Sciences (ACHV) Receivables - Other (2011 - 2023)

Achieve Life Sciences (ACHV) recorded quarterly Receivables - Other of $111000.0 in Q4 2023, up 33.73% on a QoQ basis from $83000.0 in Q3 2023, and up 5.71% year-over-year from $105000.0 in Q4 2022.

Achieve Life Sciences (ACHV) Receivables - Other (2011 - 2023) Analysis & Trends

Achieve Life Sciences has disclosed Receivables - Other across 9 years of filings, most recently posting $111000.0 for Q4 2023.

  • Quarterly Receivables - Other rose 5.71% year-over-year to $111000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $111000.0 (up 5.71% YoY) and the FY2023 annual result came in at $111000.0, up 5.71% from the prior year.
  • Receivables - Other climbed to $111000.0 in Q4 2023, from $83000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $350000.0 in Q2 2023 and troughed at $83000.0 in Q3 2023.
  • A 3-year average of $166666.7 and a median of $145000.0 in 2022 frame the typical range for Receivables - Other.
  • Biggest YoY gain for Receivables - Other was 11.82% in 2023; the steepest drop was 42.76% in 2023.
  • Tracing ACHV's Receivables - Other over 3 years: stood at $153000.0 in 2021, then plunged by 31.37% to $105000.0 in 2022, then gained by 5.71% to $111000.0 in 2023.
  • Business Quant data shows ACHV's Receivables - Other at $111000.0 in Q4 2023, $83000.0 in Q3 2023, and $350000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 Achieve Life Sciences 93.71 Mn 63.22 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 111,000.00
Dec 31, 2023 111,000.00
Sep 30, 2023 83,000.00
Sep 30, 2023 83,000.00
Jun 30, 2023 350,000.00
Jun 30, 2023 350,000.00
Mar 31, 2023 89,000.00
Mar 31, 2023 89,000.00
Dec 31, 2022 105,000.00
Dec 31, 2022 105,000.00
Sep 30, 2022 145,000.00
Sep 30, 2022 145,000.00
Jun 30, 2022 313,000.00
Jun 30, 2022 313,000.00
Dec 31, 2021 153,000.00
Dec 31, 2021 153,000.00
Sep 30, 2021 151,000.00
Sep 30, 2021 151,000.00
Dec 31, 2016 32,000.00
Dec 31, 2016 32,000.00